Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Universal Ibogaine Inc V.IBO

Alternate Symbol(s):  IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. It is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for 1-4 months, associated with elimination of addictive cravings.


TSXV:IBO - Post by User

Post by alphaflighton Jan 14, 2022 10:36pm
398 Views
Post# 34319698

Universal Ibogaine Announces Clinical Trial Partnerships

Universal Ibogaine Announces Clinical Trial Partnerships
image
 

UNIVERSAL IBOGAINE ANNOUNCES CLINICAL TRIAL PARTNERS

Dear Friends, Shareholders and Investors,

Universal Ibogaine is pleased to announce we have finalized arrangements with a world class team of researchers and regulatory consultants who will oversee our Clinical Trial application and manage the process in partnership with Health Canada to prove the safety and efficacy of ibogaine in breaking addiction.

Read the full news release here.

Completing these arrangements is a crucial step in the path to achieving our goal of helping individuals and families break the cycle of addiction, and attain a better quality of life.

We would like to thank all the people who have contributed to today's important milestone.

We see this as the first of many major steps forward in our clinical trial program, please stay tuned for further updates.

We thank you all for your continued support in our mission, we couldn't do this without you.

Nick Karos CEO

For any questions, please contact us through info@universalibogaine.com

 

Please let us know if you have have any questions or feedback, we love hearing from our community, we could not do this without you!

Profile Image Universal Ibogaine Info@UniversalIbogaine.com 1 (855) IBOGAINE - (426-4246) UniversalIbogaine.com
 
 
Facebook Twitter LinkedIn YouTube

Universal Ibogaine Inc. 595 Howe Street Suite 303 Vancouver, British Columbia V6C2T5 Canada 1 (855) 426-4246


<< Previous
Bullboard Posts
Next >>